-
Categories
health policy sites
health policy primers
HR 3590 "ObamaCare"
Category Archives: prescription drugs
Avastin & FDA: There’s No ‘Average’ Cancer Patient
Last year, the FDA began the process of revoking Avastin’s approval for breast cancer. … What is the logic of keeping terminally ill patients from potential treatments? Can’t they at least go down fighting? Continue reading
The FDA, Avastin, and death panels
“The FDA, stuck in its 1960s Thalidomide glory days mindset, denies Americans access to life-saving drugs. …[D]espite its intentions, [the FDA] drives up the costs of medicines & often dries up the supply chain altogether. America is currently facing a shortage of about 246 drugs – a record high.” – Milton Wolf, MD Continue reading
Posted in Policy - National, PPC, prescription drugs, regulation
Tagged death panels, FDA, rationing health care United States
Leave a comment
How the FDA limits access to life-savings drugs
The FDA makes the production of life-saving medications prohibitively expensive. There are better alternatives to the FDA’s authoritarian practice of banning new drugs. Continue reading
Hey FDA, government doesn’t ban cars because people drive them off cliffs
The government doesn’t ban cars just because some idiots drive cars off cliffs; it doesn’t ban pencils because pencils can be shoved into the eye; and it [e.g., the FDA] has no business banning a painkiller just because some patients don’t know how to use it correctly. Continue reading
The FDA, Avastin, and your life
Paul Hsieh, MD of Freedom and Individual Rights in Medicine writes: The Food and Drug Administration (FDA) is on the verge of taking the highly unusual step of “decertifying” the cancer drug Avastin that it had previously approved. In addition … Continue reading
FDA’s History Reveals Power Plays Produced No Health Benefits
So says a press release from the Independent Institute: Oakland, CA, Feb. 10, 2010—The Food and Drug Administration (FDA) has requested a $4.03 billion budget for FY2011, a 23 percent increase over last year. Prompted by the FDA’s vast reach … Continue reading
Health “reform” vs. medical technology & innovation
From a new Cato Institute policy analysis, Bending the Productivity Curve: Why America Leads the World in Medical Innovation: The health care issues commonly considered most important today — controlling costs and covering the uninsured — arguably should be regarded … Continue reading
Reduce drug prices by reducing FDA’s authority
David R. Henderson and Charles L. Hooper have an excellent column in Forbes. An excerpt: Do you need a government agency to tell you which TV has a vivid picture? Do you need a government agency to tell you which … Continue reading
Colorado “cares,” but markets provide
From the Denver Post: Gov. Bill Ritter suffered a quiet loss Tuesday when the Senate gave initial approval to a bill that would repeal a program created by the first bill he signed into law. The Colorado Cares Rx Program … Continue reading
Posted in Colorado health care, prescription drugs
Tagged Colorado Cares, Colorado health care, medications
Leave a comment
The FDA’s Big Bad Wolfe
Charles L. Hooper and David R. Henderson in Forbes: Since Barack Obama was elected, there has been much hopeful talk about addressing this country’s health care problems. Unfortunately, some of the ideas discussed have been bad ones and, therefore, will … Continue reading